Insider · CIK 0001847923
Max C Wygod
Files at FORA (Forian Inc.). First filing Feb 13, 2025, latest Feb 18, 2025.
Max C Wygod files SEC Form 4 as CEO, president, chair, director and 10% owner at FORA (Forian Inc.). Since Feb 13, 2025, Max C Wygod has reported 2 open-market buys worth $45k and 0 open-market sells worth $0, the latest filed on Feb 18, 2025.
A track record needs three past buys with six months of prices behind them; Max C Wygod has 0, so none is measured yet.
The newest scored trade: bought $2,605 of FORA on Feb 14, 2025, filed Feb 18, 2025, scored 25 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | FORAbuy Forian Inc. | $2,605 880 shares | +0% | - | |
| 31Weak | FORAbuy Forian Inc. | $42k 15,867 shares | +1% | - |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | FORA Forian Inc. | DDisposition to issuer Common Stock | -1,278,927 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | FORA Forian Inc. | DDisposition to issuer Common Stock | -250,000 | - | - | 0 | May 15, 2026 |
| Jul 15, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +200,000 | $1.93 | $386k | 1,528,927 | Jul 17, 2025 |
| Feb 14, 2025 | FORA Forian Inc. | POpen-market purchase Common Stock | +880 | $2.96 | $2,605 | 1,328,927 | Feb 18, 2025 |
| Feb 11, 2025 | FORA Forian Inc. | POpen-market purchase Common Stock | +770 | $2.87 | $2,210 | 1,312,950 | Feb 13, 2025 |
| Feb 11, 2025 | FORA Forian Inc. | POpen-market purchase Common Stock | +11,550 | $2.66 | $31k | 1,324,500 | Feb 13, 2025 |
| Feb 12, 2025 | FORA Forian Inc. | POpen-market purchase Common Stock | +1,747 | $2.52 | $4,402 | 1,326,247 | Feb 13, 2025 |
| Feb 13, 2025 | FORA Forian Inc. | POpen-market purchase Common Stock | +1,800 | $2.73 | $4,914 | 1,328,047 | Feb 13, 2025 |
| Feb 6, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +1,800 | $2.48 | $4,464 | 1,308,380 | Feb 10, 2025 |
| Feb 7, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +2,000 | $2.49 | $4,980 | 1,310,380 | Feb 10, 2025 |
| Feb 10, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +1,800 | $2.45 | $4,410 | 1,312,180 | Feb 10, 2025 |
| Feb 3, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +2,600 | $2.24 | $5,824 | 1,303,180 | Feb 5, 2025 |
| Feb 4, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +1,700 | $2.35 | $3,995 | 1,304,880 | Feb 5, 2025 |
| Feb 5, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +1,700 | $2.42 | $4,114 | 1,306,580 | Feb 5, 2025 |
| Jan 29, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +1,700 | $2.32 | $3,944 | 1,296,272 | Jan 31, 2025 |
| Jan 30, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +1,708 | $2.26 | $3,860 | 1,297,980 | Jan 31, 2025 |
| Jan 31, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +2,600 | $2.24 | $5,824 | 1,300,580 | Jan 31, 2025 |
| Jan 23, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +3,822 | $2.10 | $8,026 | 1,286,572 | Jan 27, 2025 |
| Jan 24, 2025 | FORA Forian Inc. | AGrant or award Common Stock | +8,000 | $2.24 | $18k | 1,294,572 | Jan 27, 2025 |
Questions about Max C Wygod
Answered from the filings on this page, as of the latest one.
Is Max C Wygod buying or selling?
Not in the last 12 months. Max C Wygod's latest open-market trade on SEC Form 4 was bought $2,605 of FORA on Feb 14, 2025.
How did Max C Wygod's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Max C Wygod has 0.
Where does Max C Wygod file Form 4?
Max C Wygod has filed Form 4 at FORA (Forian Inc.) as Exec Chairman, CEO & President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.